In 2014 year, transluminal endoscopic step-up approach was conditionally admitted to the basic package for 4 years for treatment of infected pancreatic necrosis. This conditional admission runs until 1st of January, 2018.
Efficacy and safety data was recorded in a randomized study to compare with the current standard practice during 4 years. These data demonstrated this approach as effective and safe procedure for treatment of patients with infected pancreatic necrosis.
Therefore, the Dutch National Health Care Institute (Zorginstituut Nederland) concluded that transluminal endoscopic step-up approach satisfies criteria “state of science and practice” in considered indication. The method can be reimbursed within basic health insurance.
See full-text position paper in Dutch here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.